Explaining sex difference in cancer risk: Might it be related to excess iron?

International Journal of Cancer

Volumn 133, Issue 9, 2013, Pages 2261-2262

  Mascitelli, Luca ^a   Goldstein, Mark R ^b  

^a Comando Brigata Alpina Julia Medical Service ^*  (Italy)

^b NCH Healthcare Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; FERRITIN; IRON; REACTIVE OXYGEN METABOLITE;

AGE; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CAUSE OF DEATH; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON STORAGE; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE;

CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRON; IRON OVERLOAD; MALE; NEOPLASMS; PROGNOSIS; SEX FACTORS; SURVIVAL RATE;

EID: 84882574742     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28240     Document Type: Letter

References (10)

1. Cook MB, McGlynn KA, Devesa SS, et al. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev 2011; 20: 1629-37.
2. Cancer Statistics Report. Excess cancer burden in men. Available at http://publications.cancerresearchuk.org/downloads/product/CS-REPORT- EXCESSBURDEN.pdf, accessed on April 23, 2013.
3. Eisenstein RS,. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000; 20: 627-62.
4. Huang X,. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 2003; 533: 153-71.
5. Karihtala P, Soini Y,. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007; 115: 81-103.
6. Wiseman H, Halliwell B,. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996; 313 (Pt 1): 17-29.
7. Toyokuni S,. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553-66.
8. Richardson DR, Kalinowski DS, Lau S, et al. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 2009; 1790: 702-17.
9. Sullivan J,. Is stored iron safe? J Lab Clin Med 2004; 144: 280-4.
10. Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 2008; 100: 996-1002.